By combining the various technologies of the Fujifilm Group companies (FUJIFILM Biotechnologies, FUJIFILM Biosciences, FUJIFILM Cellular Dynamics, Inc., FUJIFILM Wako Pure Chemical Corporation, FUJIFILM Toyama Chemical Co., Ltd., etc.) and advanced production-control and quality-control technologies, etc., developed in the field of photographic film, pharmaceutical and life science products have been and are being developed, manufactured, and marketed. In recent years, business has also expanded in the area of Bio CDMO, which perform process development and production of biological formulations under contract, and drug discovery support, based on total solutions involving cells, media, and reagents, is contributing to expansion of pharmaceutical industry and progress in biomedicine. By responding to unmet medical needs, such as cancer and rare diseases, for which no effective treatment methods have been established, we are tackling the resolution of various societal problems linked to health and medicine.